| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.22 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |